https://doi.org/10.4081/hmr.v2i7.406

New approaches to front-line therapy in multiple myeloma patients aged over 60 years

Vol. 2 No. 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006
Published: June 8, 2009
Abstract Views: 163
PDF: 174
Untitled (): 0
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

JF San-Miguel
support@pagepress.org
MV Mateos
High dose therapy followed by autologous stem cell support (ASCT) represents the standard of care for younger myeloma patients. However, half of MM patients are >70 years at diagnosis and other have comorbidetes which preclude ASCT. For more than 30 years Melphalan-Prednisone (MP) has been the standard treatment for elderly MM patients, although the response rate (RR) is only 40-50% and complete responses (CR) are rare. Median duration of response to MP is 1.5 years and median O.S is 2-3 years.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

San-Miguel, J., & Mateos, M. (2009). New approaches to front-line therapy in multiple myeloma patients aged over 60 years. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.406
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).